[ Trice Medical raises $19.3M in Series C funding ]

Trice Medical has raised $19.3 million in Series C funding.

Founded in 2011, Trice Medical focuses on developing orthopedic diagnostics devices with integrated camera-enabled technologies for patients, physicians and payors.

The round will go toward accelerating and expanding the company’s U.S. market reach for its flagship product, a handheld diagnostics tool called mi-eye, as well as research and development, sales, marketing and key international regulatory approvals.

Funding  Series C
Founded  2011
Country  USA
City  King Of Prussia, Pennsylvania
Founder / CEO  Jeffrey F. O’Donnell
Deal Size  $19.3M
Investors  Smith & Nephew
 Safeguard Scientifics
Previous Investors  BioStar Ventures
 HealthQuest Capital
 Safeguard Scientifics